↓ Skip to main content

Metformin attenuates plaque-associated tau pathology and reduces amyloid-β burden in APP/PS1 mice

Overview of attention for article published in Alzheimer's Research & Therapy, February 2021
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (85th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (56th percentile)

Citations

dimensions_citation
61 Dimensions

Readers on

mendeley
84 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Metformin attenuates plaque-associated tau pathology and reduces amyloid-β burden in APP/PS1 mice
Published in
Alzheimer's Research & Therapy, February 2021
DOI 10.1186/s13195-020-00761-9
Pubmed ID
Authors

Yanxing Chen, Shuai Zhao, Ziqi Fan, Zheyu Li, Yueli Zhu, Ting Shen, Kaicheng Li, Yaping Yan, Jun Tian, Zhirong Liu, Baorong Zhang

X Demographics

X Demographics

The data shown below were collected from the profiles of 7 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 84 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 84 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 10 12%
Researcher 10 12%
Student > Master 8 10%
Student > Bachelor 7 8%
Student > Doctoral Student 5 6%
Other 5 6%
Unknown 39 46%
Readers by discipline Count As %
Medicine and Dentistry 10 12%
Biochemistry, Genetics and Molecular Biology 9 11%
Neuroscience 9 11%
Pharmacology, Toxicology and Pharmaceutical Science 7 8%
Immunology and Microbiology 2 2%
Other 7 8%
Unknown 40 48%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 13. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 November 2021.
All research outputs
#2,436,890
of 23,278,709 outputs
Outputs from Alzheimer's Research & Therapy
#557
of 1,264 outputs
Outputs of similar age
#71,756
of 512,894 outputs
Outputs of similar age from Alzheimer's Research & Therapy
#29
of 67 outputs
Altmetric has tracked 23,278,709 research outputs across all sources so far. Compared to these this one has done well and is in the 89th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,264 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 25.9. This one has gotten more attention than average, scoring higher than 55% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 512,894 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 85% of its contemporaries.
We're also able to compare this research output to 67 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 56% of its contemporaries.